PHARMACEUTICALS AND MEDICAL EQUIPMENT IN CANADA

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

After A Challenging Period, Exports To Rebound Starting 2019

Ageing Society To Continue Driving Substantial Domestic Demand

Strong Growth of Medical Device Production To Facilitate Further Industry Development

Competitive Landscape

Local Producers Improve International Standing Through Lowering Prices

New Foreign Agreements Bring Additional Pressure on Local Producers

Industry Overview

Chart 1 Turnover

Chart 2 Value Added , LCU million

Chart 3 Profit and Profit Margin

Chart 4 Turnover by Category , LCU million

Chart 5 Pharmaceuticals Turnover

Chart 6 Medical and Surgical Equipment Turnover

Chart 7 Absolute Growth by Category, LCU million

Cost Structure

Chart 8 Cost Structure , LCU million

Chart 9 Costs' Structure

Trade

Chart 10 Imports, Exports and Trade Balance , LCU million

Chart 11 Exports by Category

Chart 12 Exports by Country , LCU million

Chart 13 Imports by Category

Chart 14 Imports by Country , LCU million

Market Structure

Chart 15 Market Structure , LCU million

Chart 16 Market Structure by Category , LCU million

Buyers

Chart 17 Market Structure by Buyer

Chart 18 Demand Structure

Firmographics

Chart 19 Employment Statistics and Productivity

Chart 20 Number of Companies by Company's Size

Chart 21 Firmographics Distribution by Company Size , % of total companies

Chart 22 Firmographics Distribution by Turnover , % of total Turnover

Chart 23 Industry Concentration , % share of Turnover

Chart 24 Top Companies' Shares , % of Turnover

Chart 25 Top Companies' Share Dynamics , % of Turnover

Chart 26 Turnover Performance by Company

Industry Context

Chart 27 Industry vs GDP Performance , % YOY growth

Chart 28 Pharmaceuticals and Medical Equipment vs Other Industries , LCU million

Chart 29 Industry Turnover by Region , USD million

Chart 30 Pharmaceuticals and Medical Equipment in North America , USD million

Canadian producers registered weaker turnover growth in 2017, impeded by falling drug exports to the US, which dropped by 32% in value on the back of plunging generic drug prices, increasing competition and a consolidating customer base. Lower generic prices also took a toll on producers’ profits, which fell by 12% over the year. Exports are expected to recover in 2019. Teva, Mylan, Endo, Sandoz (Novartis) and other major generic producers have started to discontinue unviable generic drugs in th...

Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals and Medical Equipment market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Product coverage: Medical and Surgical Equipment, Pharmaceuticals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Pharmaceuticals and Medical Equipment market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.